The ASX fell 0.25pc this morning as Trump announced pharmaceutical tariffs, with copper, silver and uranium stocks providing ...

Simulations Plus is completely oversold, with investor pessimism nearly universal. Read why SLP stock offers significant ...

Crinetics’ PALSONIFY wins FDA approval as a new oral treatment for acromegaly, offering rapid, effective symptom control.

Frank Menniti shares lab space for his work as chief science officer for a company developing a new drug for Alzheimer’s ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit speaks with PanCAN’s Chief Business Officer, Sudheer Doss, PhD, ...

What was once a problem of square footage is now a question of readiness. Only those who invest ahead of demand while staying lean and interoperable will be able to support the next wave of complex ...

As Trump’s speech to the United Nations slides into grievance and solipsism, a sharp observer of global affairs explains the ...

We spoke with Castle Bioscience's Dr. Rebecca Critchley-Thorne about AI-enabled spatial proteomics, TissueCypher’s impact on ...

Hospitals worldwide, including Germany, face a growing problem with fungal infections, with an estimated 6 million cases and ...

In the field of pathology, the integration of artificial intelligence (AI) and genomics is paving the way for precision diagnostics that were once thought ...

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...